| JNTL Consumer Health II (Switzerland) GmbH - Vermox 500 mg, Tabletten | | 38853 | | 02 | | Vermox 500 mg | | Tabletten | | P02CA01 | | Mebendazole | | 20.09.1989 | | |
| | Composition | | mebendazolum 500 mg, lactosum monohydricum 34 mg, methylcellulosum, carboxymethylamylum natricum A corresp. natrium 2.23 mg, cellulosum microcristallinum, maydis amylum, magnesii stearas, silica colloidalis anhydrica, pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Mebendazole | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Mebendazole | 500 mg |
| | | | Inactive agents | Dose |
|---|
| Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | Lactose Monohydrate | 34 mg | | Magnesii Stearas | | | Maydis Amylum | | | Methylcellulosum | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 023 | 100 Tablet(s) | 152.20 | 181.95 | B | | Yes |
|
|
